Leidos Wins $301M Army Contract to Strengthen Military Cyber Defenses

Leidos Holdings (LDOS), a defense and tech services company, has underperformed the market and sector ETFs due to contract issues and government budget constraints. Despite this, LDOS reported strong Q2 earnings, beating estimates with $3.26 adjusted EPS and $4.6B revenue. Analysts have a 'Moderate Buy' consensus, with a mean price target of $160.12, implying 11.6% upside. Wells Fargo raised its target to $165, suggesting 15% potential gain.

Pentagon deputy secretary Steve Feinberg asked major U.S. defense firms to accelerate production and deliveries of weapons and sensors, citing concerns about shortages and gaps tied to the Iran conflict. In an Aug. 5 letter seen by Bloomberg, he targeted programs including wide-area surveillance, air-defense sensors and interceptors, and missile-tracking systems, asking for plans by late August.

Leidos Holdings reported record Q2 2026 revenue of $4.6 billion and a 1.1 book-to-bill ratio, with Defense at a 2.2 book-to-bill. Full-year revenue guidance was raised by $100 million at the midpoint. Health faces VA incentive payment suspension, while Homeland grew 32%. Capex guidance was cut to about $250 million and share repurchases were authorized.

DHS awarded 14 positions on a $1.5B counter-drone IDIQ, split into Track 1 (ceiling $1.01B) for hardware and services and Track 2 (ceiling $489M) for comprehensive services, per USAspending. Leidos and BAE Systems won both tracks; others received single-track spots. Ordering runs Aug. 1, 2026 to July 31, 2031, with a $250M minimum guarantee at award.

Leidos said it won a contract with the Office of Naval Intelligence worth up to $64.8 million, including a base year and four option years, to continue modernizing naval intelligence communications infrastructure. The work builds on Leidos efforts since 2021 and supports the Hopper Global Communications Center, aimed at secure information sharing and technology integration, according to the company.

Stifel cut its Leidos Holdings (NYSE:LDOS) price target to $142 from $193 and kept a Hold rating, citing concerns about the company’s Health segment despite strong Q2 results. Leidos reported adjusted EPS of $3.26 vs $2.91 expected and revenue of $4.56B vs $4.44B, raised full-year 2026 guidance, and saw organic revenue growth of 4% YoY.